Physician profile
Craig Jackson
NPI 1275962581
$850.36
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $270 · 2021: $266.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $180.34 | 2019-2021 | |
| Lilly USA, LLC | $108.43 | 2019-2021 | |
| Pfizer INC. | $94.44 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $80.76 | 2020 | |
| Glaxosmithkline, LLC. | $59.02 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $47.65 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $43.93 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $43.38 | 2019-2020 | |
| Amgen INC. | $34.17 | 2019-2021 | |
| Daiichi Sankyo INC. | $29.92 | 2019-2021 | |
| Abbvie INC. | $26.96 | 2021 | |
| Astellas Pharma US INC | $24.57 | 2021 | |
| Amarin Pharma, INC. | $23.31 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $18.33 | 2021 | |
| Allergan, INC. | $11.87 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $11.80 | 2019 | |
| Novo Nordisk INC | $11.48 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.